Filing Details

Accession Number:
0001225208-11-012576
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-29 15:37:10
Reporting Period:
2011-04-28
Filing Date:
2011-04-29
Accepted Time:
2011-04-29 15:37:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI Biological Products, (No Disgnostic Substances) (2836) 223178468
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1332456 Barry Labinger 14200 Shady Grove Road
Rockville MD 20850
Exec Vp & Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-28 28,113 $0.52 28,113 No 4 M Direct
Common Stock Acquisiton 2011-04-28 11,853 $4.92 39,966 No 4 M Direct
Common Stock Disposition 2011-04-28 11,853 $30.00 28,113 No 4 S Direct
Common Stock Disposition 2011-04-28 28,113 $30.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option - Right to Buy Disposition 2011-04-28 11,853 $0.00 11,853 $4.92
Common Stock Employee Stock Option - Right to Buy Disposition 2011-04-28 28,113 $0.00 28,113 $0.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
59,018 2018-03-10 No 4 M Direct
75,020 2019-03-10 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective March 18, 2011.
  2. One-eighth of the 150,000 options granted on March 10, 2008, vested on the six-month anniversary date (September, 2008) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2008.
  3. One-eighth of the 150,000 options granted on March 10, 2009, vested on the six-month anniversary date (September, 2009) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2009.